Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4641-4648

  Kowolik, C M ^a   Hu, J ^a   Yee, J K ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN CD2; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE TARGETING; GENE THERAPY; GENETIC STABILITY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; MOLECULAR CLONING; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; T LYMPHOCYTE; TRANSGENE;

ANTIGENS, CD2; CELL LINE, TRANSFORMED; CELLS, CULTURED; GENE DOSAGE; GENE EXPRESSION; GENETIC VECTORS; GLOBINS; HIV-1; HUMANS; JURKAT CELLS; LOCUS CONTROL REGION; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0035037078     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4641-4648.2001     Document Type: Article

References (54)

1. Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice
2. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
4. Development of lentiviral vectors for gene therapy for human diseases
5. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
6. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
7. A 36-base-pair core sequence of locus control region enhances retrovirally transferred human beta-globin gene expression
8. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors
9. A locus control region in the T cell receptor alpha/delta locus
10. Locus control region function and heterochromatin-induced position effect variegation
11. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus
12. Progress toward human gene therapy
13. Promoter traps in embryonic stem cells: A genetic screen to identify and mutate developmental genes in mice
14. Transcription in vivo from SV40 early promoter deletion mutants without repression by large T antigen
15. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyo- pherin pathway
16. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors
17. A new technique for the assay of infectivity of human adenovirus 5 DNA
18. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice
19. Position-independent, high-level expression of the human beta-globin gene in transgenic mice
20. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position
21. Human T lymphocyte genetic modification with naked DNA
22. The human growth hormone gene is regulated by a multicomponent locus control region
23. Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid
24. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
25. Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo
26. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
27. A 3′ transcriptional enhancer regulates tissue-specific expression of the human CD2 gene
28. Deletion analysis of the human CD2 gene locus control region in transgenic mice
29. Mutagenesis of retroviral vectors transducing human beta-globin gene and beta-globin locus control region derivatives results in stable transmission of an active transcriptional structure
30. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus
31. Development of viral vectors for gene therapy of beta-chain hemoglobinopathies: Optimization of a gamma-globin gene expression cassette
32. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin
33. Retroviral vector sequences inhibit human beta-globin gene expression in transgenic mice
34. Retroviral vectors
35. Development of a self-inactivating lentivirus vector
36. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector
37. Functional properties of the beta-globin locus control region in K562 erythroleukemia cells
38. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
39. High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells
40. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes
41. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes
42. A human beta-globin gene fused to the human beta-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells
43. Long-term transfer and expression of the human beta-globin gene in a mouse transplant model
44. Site-independent expression of the chicken beta A-globin gene in transgenic mice
45. Genetic treatment of severe hemoglobinopathies: The combat against transgene variegation and transgene silencing
46. A single erythroid-specific DNase I super-hypersensitive site activates high levels of human beta-globin gene expression in transgenic mice
47. Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: Dual gene expression in the context of HIV-2 LTR and Tat
48. Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene
49. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer
50. Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo
51. Factors affecting long-term stability of Moloney murine leukemia virus-based vectors
52. A general method for the generation of high-titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes
53. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery